National Bank of Canada
GTHX

National Bank of Canada’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

National Bank of Canada’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$10K – 3058
2021
Q4 		$10K Buy
+1,000
New +$12.7K ﹤0.01% 2371

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

National Bank of Canada's GTHX Position: Q1 2022 in Review

National Bank of Canada sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2022, closing a stake of 1,000 shares — an estimated $10K sold.

National Bank of Canada first reported a position in GTHX in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 115 funds tracked by Wall St. Rank hold GTHX as of Q1 2022.

  • National Bank of Canada reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • National Bank of Canada sold 1,000 G1 Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $10K.
  • National Bank of Canada first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • National Bank of Canada's G1 Therapeutics, Inc. Common Stock position peaked at $10K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2022.

Based on National Bank of Canada's 13F filing for Q1 2022, filed 5 May 2022.